Genetic or pharmacological activation of the HIF pathway in cellular and zebrafish models, as well as chronic normobaric hypoxic treatment in the murine Ndufs4 ko model of Leigh syndrome, prevented the development of the disease. This evidence concerns the gene NDUFS4 and Leigh syndrome.